August 25, 2025

Akero Therapeutics (AKRO) Investor Outlook: Analysts See 54.93% Upside Potential

Investors eyeing Akero Therapeutics, Inc. (NASDAQ: AKRO) will find a compelling case for potential growth, driven by the company’s focus on breakthrough treatments for serious metabolic diseases. With a market..

Encompass Health (EHC) Stock Analysis: A Promising 10.52% Potential Upside in Healthcare

Encompass Health Corporation (NYSE: EHC), a leader in the healthcare sector focusing on medical care facilities, presents a compelling investment opportunity with a potential upside of 10.52%. With a robust..

Veeva Systems Inc. (VEEV) Stock Analysis: A Closer Look at Its 3.41% Potential Upside

Veeva Systems Inc. (NYSE: VEEV) stands as a leading provider of cloud-based software solutions tailored specifically for the life sciences industry. With a current market capitalization of $47.53 billion, Veeva..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Exploring the 89.39% Return on Equity and Its Impact on Investor Decisions

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, has been capturing attention with its impressive financial metrics. As of..

Revvity, Inc. (RVTY) Stock Analysis: Unveiling a 24% Upside Potential in the Healthcare Sector

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, is drawing significant investor attention with its robust potential upside of 24.07%. As a key entity in the diagnostics and..

argenx SE (ARGX) Stock Analysis: Unpacking a 22% Potential Upside in the Biotech Giant

argenx SE (ARGX), a biotechnology powerhouse based in the Netherlands, is capturing investor attention with its impressive growth trajectory and innovative therapeutic portfolio. With a market capitalization of $41.07 billion,..

Stevanato Group S.p.A. (STVN) Stock Analysis: Examining 26.60% Potential Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), a powerhouse in the healthcare sector, particularly in the medical instruments and supplies industry, offers a compelling opportunity for investors seeking exposure to the biopharmaceutical..

Integer Holdings Corporation (ITGR)

⚠️ No article content returned.

..

Revolution Medicines, Inc. (RVMD): Analyzing Nearly 96% Upside Potential in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage biotechnology firm specializing in precision oncology, is capturing investor attention with a striking potential upside of 95.62%, driven by an average target price..

Biogen Inc. (BIIB) Stock Analysis: Exploring the 21.63% Potential Upside

Biogen Inc. (NASDAQ: BIIB), a key player in the healthcare sector, continues to capture the attention of investors with its innovative therapies aimed at treating neurological and neurodegenerative diseases. With..

Elevance Health, Inc. (ELV) Stock Analysis: A Promising 16% Upside with Strong Analyst Endorsement

Investors eyeing the healthcare sector may find Elevance Health, Inc. (NYSE: ELV) an enticing prospect, particularly given its substantial market presence and potential upside. With a market capitalization of $71.28..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 22.57% Upside Potential in the Healthcare Tech Giant

Intuitive Surgical, Inc. (NASDAQ: ISRG), a vanguard in the medical instruments and supplies industry, remains a pivotal player in the healthcare sector with its cutting-edge technology. Headquartered in Sunnyvale, California,..

Vaxcyte, Inc. (PCVX) Investor Outlook: Analyzing the 255.76% Potential Upside in the Biotechnology Sector

Investors eyeing the biotechnology sector have a compelling opportunity to consider in Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage vaccine innovation company. With a market cap of $4.19 billion, Vaxcyte stands..

McKesson Corporation (MCK) Stock Analysis: Healthcare Giant’s Strategic Position and 14% Upside

McKesson Corporation (NYSE: MCK), a cornerstone of the healthcare sector, continues to capture investor attention with its robust operational framework and promising growth potential. With a market capitalization of $85.76..

TransMedics Group, Inc. (TMDX): Investor Outlook with an 18.72% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector, specifically within the niche of medical devices. The company is dedicated to revolutionizing organ transplantation, a critical area..

BrightSpring Health Services, I (BTSG) Stock Analysis: Is a 15% Upside Worth the Investment?

Investors with an eye on the healthcare sector may want to consider BrightSpring Health Services, Inc. (BTSG), a prominent player in the Health Information Services industry. With a market capitalization..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Growth Potential and Market Position

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a formidable name in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, has consistently demonstrated its prowess in the pharmaceutical..

Axsome Therapeutics, Inc. (AXSM): A Biotech Gem with 49.31% Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors with a promising 49.31% potential upside, according to analyst target prices. The New York-based biopharmaceutical company, specializing in central..

Neurocrine Biosciences, Inc. (NBIX) Investor Outlook: Analysts See Nearly 24% Upside Potential

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a key player in the healthcare sector specializing in pharmaceuticals for neurological and neuropsychiatric disorders, is drawing significant investor attention. With a robust market capitalization..

Solventum Corporation (SOLV): Investor Outlook on a 17.9% Potential Upside

Solventum Corporation (NYSE: SOLV) is making waves in the healthcare sector, specifically within the realm of Medical Instruments & Supplies. With a market capitalization of $12.75 billion, this U.S.-based company..

Search

Funds

August 25, 2025

Search

Funds

August 25, 2025

FTSE 100

Funds